Share This Page
Suppliers and packagers for baclofen
✉ Email this page to a colleague
baclofen
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Maia Pharms Inc | BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 210777 | ANDA | Sagent Pharmaceuticals | 25021-681-71 | 2 SYRINGE in 1 CARTON (25021-681-71) / 1 mL in 1 SYRINGE | 2021-07-15 |
| Maia Pharms Inc | BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 210777 | ANDA | MAlA Pharmaceuticals, Inc. | 70511-121-80 | 2 SYRINGE, GLASS in 1 CARTON (70511-121-80) / 1 mL in 1 SYRINGE, GLASS | 2021-04-02 |
| Maia Pharms Inc | BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 210048 | ANDA | Sagent Pharmaceuticals | 25021-678-20 | 1 VIAL in 1 CARTON (25021-678-20) / 20 mL in 1 VIAL | 2021-07-15 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Baclofen
Introduction
Baclofen, a gamma-aminobutyric acid (GABA) B receptor agonist, is primarily used as a muscle relaxant to treat spasticity related to multiple sclerosis, spinal cord injuries, and other neurological conditions. As an essential therapeutic agent, the global supply chain for baclofen involves various manufacturing entities, distributors, and regulatory frameworks ensuring drug availability and quality. This article provides an in-depth analysis of key suppliers, manufacturing industry dynamics, regulatory considerations, and market trends relevant to baclofen procurement for healthcare providers, pharmaceutical companies, and stakeholders.
Global Manufacturing Landscape
Major Manufacturers of Baclofen
Baclofen's manufacturing landscape is characterized by a combination of established pharmaceutical giants, generic drug producers, and contract manufacturing organizations (CMOs). The drug's chemical synthesis involves relatively straightforward processes, allowing a broad spectrum of suppliers to produce and supply it globally.
-
Pharmaceutical Giants
Leading multinational companies such as Pfizer, Novartis, and AstraZeneca have historically supplied baclofen as branded or generic products. Although these companies may not always produce baclofen directly, they often distribute it through their global networks. -
Generic Manufacturers
The majority of baclofen manufacturing is dominated by generic producers, especially in India, China, and Eastern Europe. Companies like Zydus Cadila, Sun Pharmaceutical Industries, Aurobindo Pharma, Pfizer India, and CTS Pharma are prominent players supplying generic baclofen formulations and Active Pharmaceutical Ingredients (APIs). -
Contract Manufacturing Organizations (CMOs)
Numerous CMOs specialize in bulk API production of baclofen, providing APIs to branded and generic drug manufacturers. These organizations often operate under strict Good Manufacturing Practice (GMP) standards to ensure product quality and regulatory compliance.
API Production and Supply Chains
The API production process for baclofen is well-established, with key production hubs in India, China, and Eastern Europe. These regions benefit from cost advantages and manufacturing expertise. The APIs are then supplied to a network of formulators worldwide for finished drug production.
Regulatory and Quality Considerations
Given the importance of high-quality API and finished formulations, regulatory approval by agencies such as the US FDA, EMA, and PMDA impacts supplier selection.
-
Regulatory Certifications: Suppliers must maintain GMP compliance, often verified through audits and certification, ensuring consistent product quality.
-
Quality Standards: Suppliers adhering to the latest USP, EP, or JP monographs for baclofen are preferred. Strict quality control measures minimize differences in potency, stability, and bioavailability.
Key Suppliers and Market Players
| Company / Region | Role | Notes |
|---|---|---|
| Indian Manufacturers | Major API donors | Zydus Cadila, Aurobindo Pharma, Sun Pharma, Cipla |
| Chinese Suppliers | API production | Shanghai ChemPartner, Zhejiang Huahai Pharmaceutical |
| European Manufacturers | API and formulations | Dr. Reddy’s Laboratories (India-based, operational globally), Consiliums from EU in compliance with EMA standards. |
| American Suppliers | API and finished products | Mostly importers, US market relies heavily on imports from India and Europe. |
Market Trends and Dynamics
Growth Drivers
- Increasing Prevalence of Spasticity: Rising neurological disorder rates expand the demand for baclofen, fueling supplier growth.
- Expanding Generics Market: Price sensitivity in emerging markets favors generic suppliers, increasing baclofen availability.
- Regulatory Harmonization: Stringent quality standards in developed markets encourage suppliers to invest in GMP certification, broadening supplier acceptance.
Supply Chain Challenges
- Regulatory Barriers: Variations in regulatory approval across jurisdictions can delay supplier onboarding or product approval.
- Raw Material Sourcing: Dependence on raw material suppliers in China and India introduces risks related to geopolitical tensions and supply disruptions.
- Quality Assurance Variability: Differing manufacturing standards necessitate rigorous supplier qualification processes.
Future Outlook
The baclofen supply landscape will likely experience consolidation among API producers, with increased investments in quality infrastructure. Regulatory harmonization efforts aim to streamline approval processes across markets. The proliferation of CNF (contract and formulation manufacturing) further diversifies supplier bases, ensuring resilient supply chains.
Key Takeaways
- Diverse Supplier Base: The global baclofen supply chain relies heavily on Indian and Chinese API manufacturers, complemented by regional formulators.
- Regulatory Compliance Is Critical: Suppliers adhering to GMP standards and regulatory clearances are essential for market access.
- Market Growth Favors Generics: Cost-effective generic producers in emerging markets dominate the supply, with steady growth driven by rising neurological disease prevalence.
- Supply Chain Risks: geopolitical factors, raw material sourcing, and quality variability present ongoing challenges.
- Strategic Sourcing Is Vital: Stakeholders should prioritize suppliers with proven compliance, quality assurance, and scalable capacity to mitigate disruptions.
FAQs
Q1: Who are the leading global suppliers of baclofen API?
A1: Indian companies like Zydus Cadila, Aurobindo Pharma, and Sun Pharma are major API suppliers, with Chinese firms such as Zhejiang Huahai also playing significant roles.
Q2: What criteria should organizations consider when selecting baclofen suppliers?
A2: Key criteria include GMP compliance, regulatory certifications, consistent quality, supply reliability, and capacity for scale.
Q3: How do regulatory standards influence baclofen supplier choices?
A3: Regulatory standards like those from the FDA or EMA dictate supplier qualification; non-compliance can prevent market access and impact drug safety.
Q4: Are there any recent disruptions affecting baclofen supply chains?
A4: Supply disruptions can occur due to raw material shortages, geopolitical issues, or regulatory delays, especially in regions heavily reliant on Chinese and Indian API manufacturers.
Q5: What are the emerging trends affecting baclofen supplier strategies?
A5: Trends include increased investment in quality infrastructure, harmonization of global regulations, and the growth of contract manufacturing organizations offering flexible production capabilities.
Sources
- [1] U.S. Food and Drug Administration (FDA). API manufacturer inspection reports. FDA.gov.
- [2] Pharmaceutical Technology. "Global API Market Overview." PharmTECH.com.
- [3] Indian Pharmaceutical Alliance. Market report on API manufacturers in India. IPAIndia.org.
- [4] European Medicines Agency (EMA). Regulatory guidelines for GMP and API quality standards. EMA.europa.eu.
- [5] IQVIA. Global Generic Pharmaceutical Market Analysis. IQVIA.com.
This comprehensive overview equips business professionals with strategic insights into baclofen’s supply landscape, essential for informed procurement, partnership decisions, and risk management.
More… ↓
